GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Atara Biotherapeutics Inc (LTS:0HIY) » Definitions » 3-Year EPS without NRI Growth Rate

Atara Biotherapeutics (LTS:0HIY) 3-Year EPS without NRI Growth Rate : 14.30% (As of Dec. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Atara Biotherapeutics 3-Year EPS without NRI Growth Rate?

Atara Biotherapeutics's EPS without NRI for the three months ended in Dec. 2023 was $-0.56.

During the past 3 years, the average EPS without NRI Growth Rate was 14.30% per year. During the past 5 years, the average EPS without NRI Growth Rate was 15.40% per year. During the past 10 years, the average EPS without NRI Growth Rate was -6.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

During the past 12 years, the highest 3-Year average EPS without NRI Growth Rate of Atara Biotherapeutics was 21.60% per year. The lowest was -62.50% per year. And the median was 4.75% per year.


Competitive Comparison of Atara Biotherapeutics's 3-Year EPS without NRI Growth Rate

For the Biotechnology subindustry, Atara Biotherapeutics's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Atara Biotherapeutics's 3-Year EPS without NRI Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Atara Biotherapeutics's 3-Year EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Atara Biotherapeutics's 3-Year EPS without NRI Growth Rate falls into.



Atara Biotherapeutics 3-Year EPS without NRI Growth Rate Calculation

This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.


Atara Biotherapeutics  (LTS:0HIY) 3-Year EPS without NRI Growth Rate Explanation

EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.


Atara Biotherapeutics 3-Year EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Atara Biotherapeutics's 3-Year EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Atara Biotherapeutics (LTS:0HIY) Business Description

Industry
Traded in Other Exchanges
Address
2380 Conejo Spectrum St, Suite 200, Thousand Oaks, CA, USA, 91320
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).

Atara Biotherapeutics (LTS:0HIY) Headlines

No Headlines